{"id":8743,"date":"2021-12-17T03:03:18","date_gmt":"2021-12-17T08:03:18","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/acetate-dexenatide-cas-141732-76-5-utilise-comme-agent-hypoglycemiant-enteral\/"},"modified":"2021-12-17T03:03:18","modified_gmt":"2021-12-17T08:03:18","slug":"acetate-dexenatide-cas-141732-76-5-utilise-comme-agent-hypoglycemiant-enteral","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/fr\/product\/acetate-dexenatide-cas-141732-76-5-utilise-comme-agent-hypoglycemiant-enteral\/","title":{"rendered":"Ac\u00e9tate d&#39;ex\u00e9natide CAS 141732-76-5 utilis\u00e9 comme agent hypoglyc\u00e9miant ent\u00e9ral"},"content":{"rendered":"<h2><strong>Ac\u00e9tate d&#39;ex\u00e9natide CAS 141732-76-5 utilis\u00e9 comme agent hypoglyc\u00e9miant ent\u00e9ral<\/strong><\/h2>\n<p>Nom du produit\u00a0: ac\u00e9tate d&#39;ex\u00e9natide<br \/>\nSynonymes\u00a0:\u00a0Exenatide;His-Gly-Gly-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala -Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH{2}; AC\u00c9TATE D&#39;EXENATIDE (EXENDIN -4);His-Gly-Gly-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile- Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2;Exenatide Acetate;EXENATIDE ACETATE;ENFUVIRTIDE ACETATE;Extendin-4<br \/>\nCAS : 141732-76-5<br \/>\nMF\u00a0: C186H286N50O62S<br \/>\nMW\u00a0: 4244.60796<br \/>\nEINECS\u00a0: 1592732-453-0<br \/>\nCat\u00e9gories de produits\u00a0: Agonistes\u00a0;Bases et r\u00e9actifs associ\u00e9s\u00a0;Peptide\u00a0;Interm\u00e9diaires et produits chimiques fins\u00a0;Nucl\u00e9otides\u00a0; Pharmaceuticals;GLP<br \/>\nMol File: 141732-76-5.mol<\/p>\n<p>La s\u00e9quence d&#39;acides amin\u00e9s de l&#39;ac\u00e9tate d&#39;ex\u00e9natide chevauche partiellement le GLP-1 humain. Il a \u00e9t\u00e9 d\u00e9montr\u00e9 que l&#39;ac\u00e9tate d&#39;ex\u00e9natide se lie au r\u00e9cepteur humain connu du GLP-1 et l&#39;active in vitro. Cela signifie qu&#39;en incluant l&#39;AMPc (ad\u00e9nosine monophosphate cyclique) ou d&#39;autres m\u00e9canismes de signalisation intracellulaire, la synth\u00e8se d&#39;insuline d\u00e9pendante du glucose et la s\u00e9cr\u00e9tion d&#39;insuline par les cellules pancr\u00e9atiques \u03b2 dans le corps sont augment\u00e9es.<\/p>\n<p> <strong>Fonction et application de l&#39;ac\u00e9tate d&#39;ex\u00e9natide CAS 141732-76-5<\/strong><br \/>\nL&#39;application d&#39;ac\u00e9tate d&#39;ex\u00e9natide provoque une augmentation de l&#39;AMPc acineux sans stimuler la lib\u00e9ration d&#39;amylase. En tant que mim\u00e9tique des incr\u00e9tines, l&#39;ac\u00e9tate d&#39;ex\u00e9natide agit comme agoniste du r\u00e9cepteur du glucagon-like peptide-1 (GLP-1). Comme le GLP-1, bien qu&#39;ayant une activit\u00e9 prolong\u00e9e, l&#39;ac\u00e9tate d&#39;ex\u00e9natide augmente la production postprandiale d&#39;insuline et supprime la s\u00e9cr\u00e9tion de glucagon. Pour cette raison, l&#39;ac\u00e9tate d&#39;ex\u00e9natide a \u00e9t\u00e9 utilis\u00e9 comme m\u00e9dicament contre le diab\u00e8te II.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nom du produit : Ac\u00e9tate d&#39;ex\u00e9natide<br \/>\nCAS : 141732-76-5<br \/>\nMF : C186H286N50O62S<br \/>\nMW : 4244.60796<br \/>\nEINECS : 1592732-453-0<br \/>\nMol File : 141732-76-5.mol<\/p>\n","protected":false},"featured_media":2206,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[],"product_tag":[1017],"class_list":{"0":"post-8743","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_tag-exenatide-acetate-cas-141732-76-5-used-as-an-enteral-hypoglycemic-agent-fr","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product\/8743","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/comments?post=8743"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/media\/2206"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/media?parent=8743"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_brand?post=8743"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_cat?post=8743"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_tag?post=8743"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}